T0	MultiCitation 1464 1465	7
T1	MultiCitation 2113 2114	7
T2	Citation 13249 13250	7
T3	Citation 13852 13853	7
T4	Citation 14135 14136	7
T5	Citation 14523 14524	7
T6	Span 1318 1466	Molecular profiling has identified 5 distinct subtypes of human breast tumors, luminal A, luminal B, HER2-enriched, basal-like and claudin-low [1-7]
R1	Context Target:T0 Context:T6	
T7	Span 1961 2114	Claudin-low tumors express mesenchymal genes such as Twist1, Twist2, Zeb1, Zeb2, Slug and Snail and low levels of E-cadherin and claudins 3, 4 and 7 [6,7
R2	Context Target:T1 Context:T7	
T8	Span 13192 13251	Since claudin-low tumors possess features of stem cells [7]
R3	Context Target:T2 Context:T8	
T9	Span 13740 13854	These tumors have a prevalence of approximately 7-14% and a have a poor prognosis compared to luminal A tumors [7]
R4	Context Target:T3 Context:T9	
T10	Span 13856 14136	Although a number of human tumor cell lines have been identified as sharing features of claudin-low tumors (MDA-MB-435, MDA-MB-436, Hs578T, BT549, MDA-MB-231, MDA-MB-157, SUM1315MO2, SUM159PT and HBL100), fewer claudin-low, murine mammary tumor cell lines have been established [7
R5	Context Target:T4 Context:T10	
T11	Span 14351 14526	The immune status of mice may be particularly important when studying claudin-low tumors as one of the hallmarks of this tumor type is an increase in immune-related genes [7].
R6	Context Target:T5 Context:T11	
